Stoke Therapeutics Inc. (STOK)
6.16
-0.49 (-7.37%)
At close: Apr 01, 2025, 3:42 PM
Stoke Therapeutics Revenue
Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending December 31, 2024, Stoke Therapeutics generated $22.61M in revenue.
Revenue (ttm)
$36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
$285.59K
Employees
128
Market Cap
333.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 36.55M | +316.34% |
| Dec 31, 2023 | 8.78M | -29.22% |
| Dec 31, 2022 | 12.4M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |